Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T5ES
|
|||
| Former ID |
DNCL002749
|
|||
| Drug Name |
MUC-1 cancer vaccine
|
|||
| Synonyms |
CVac (TN)
Click to Show/Hide
|
|||
| Indication | Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 2 | [1] | |
| Company |
Prima BioMed Sydney
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | CVAC SHOWS OVERALL SURVIVAL BENEFIT IN SECOND REMISSION OVARIAN CANCER IN PHASE II STUDY. 19 May 2015. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.